Eli Lilly & Co. (LLY) Tops Q1 EPS by 27c, Offers FY Guidance

Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.75, $0.27 better than the analyst estimate of $1.48. Revenue for the quarter came in at $5.86 billion versus the consensus estimate of $5.51 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2020 EPS of $6.70-$6.90, versus the consensus of $6.73. Eli Lilly & Co. sees FY2020 revenue of $23.7-24.2 billion, versus the consensus of $23.84 billion.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• AeroVironment restates quarterly financials, citing $89M goodwill error
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Pfizer lung cancer drug misses survival goal in Phase 3 trial